{"id":"https://openalex.org/W7225329972","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0591","title":"591 Collagen targeting IL-12 combined with doxorubicin enhances the anti-tumor effect against osteosarcoma","display_name":"591 Collagen targeting IL-12 combined with doxorubicin enhances the anti-tumor effect against osteosarcoma","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225329972","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0591"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0591","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0591","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0591","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A665.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A665.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157787941","display_name":"Takumi Matsuo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Takumi Matsuo","raw_affiliation_strings":["Imperial Collage London, London, UK","Institute of Cancer Research, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial Collage London, London, UK","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Institute of Cancer Research, London, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032930336","display_name":"Paul H. Huang","orcid":"https://orcid.org/0000-0003-3972-5087","observed_orcids":["https://orcid.org/0000-0003-3972-5087"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul H Huang","raw_affiliation_strings":["Institute of Cancer Research, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, London, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084172811","display_name":"Jun Ishihara","orcid":"https://orcid.org/0000-0002-9083-9859","observed_orcids":["https://orcid.org/0000-0002-9083-9859"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jun Ishihara","raw_affiliation_strings":["Imperial College London, London, UK","National Cancer Center, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"National Cancer Center, Chiba, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A665","last_page":"A667"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.9509999752044678},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8220000267028809},{"id":"https://openalex.org/keywords/collagen-binding-domain","display_name":"collagen-binding domain","score":0.7279999852180481},{"id":"https://openalex.org/keywords/von-willebrand-factor","display_name":"von Willebrand factor","score":0.984000027179718},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8399999737739563},{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.7730000019073486},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.6660000085830688},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7904000282287598},{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.7271999716758728},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6618000268936157},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5716999769210815},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5658000111579895},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5634999871253967},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.5184999704360962},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4595000147819519},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4390000104904175},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3625999987125397},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.3562999963760376},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.35339999198913574},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.353300005197525},{"id":"https://openalex.org/C2779394231","wikidata":"https://www.wikidata.org/wiki/Q412310","display_name":"Von Willebrand factor","level":3,"score":0.33550000190734863},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3271999955177307},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.32019999623298645},{"id":"https://openalex.org/C2778236600","wikidata":"https://www.wikidata.org/wiki/Q592324","display_name":"Immunofluorescence","level":3,"score":0.3100000023841858},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.29260000586509705},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.289900004863739},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.28610000014305115},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2797999978065491},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27300000190734863},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2727999985218048},{"id":"https://openalex.org/C2776035513","wikidata":"https://www.wikidata.org/wiki/Q1328805","display_name":"Bone cancer","level":3,"score":0.2702000141143799},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.26759999990463257},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.265500009059906},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.26460000872612},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2632000148296356},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.25619998574256897},{"id":"https://openalex.org/C2780644872","wikidata":"https://www.wikidata.org/wiki/Q14881714","display_name":"Type I collagen","level":2,"score":0.25600001215934753},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.25589999556541443}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0591","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0591","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0591","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A665.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:eeb3a785b933412dbce3bf4b3ea81912","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/eeb3a785b933412dbce3bf4b3ea81912","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss Suppl 2 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0591","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0591","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0591","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A665.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225329972.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7214478490","https://openalex.org/W4293799884","https://openalex.org/W4238342696","https://openalex.org/W4388081354","https://openalex.org/W4404330305","https://openalex.org/W3106917602","https://openalex.org/W2139316892","https://openalex.org/W4389241614","https://openalex.org/W2950247171","https://openalex.org/W2050557709"],"abstract_inverted_index":{"Background":[0],"Osteosarcoma":[1,414],"(OS)":[2],"is":[3,59,96],"the":[4,34,52,68,93,196,274,290,327,340,425,503,536,571,590],"most":[5],"common":[6],"primary":[7,602],"bone":[8],"malignancy":[9],"in":[10,109,113,142,159,211,232,238,259,384,587],"children":[11],"and":[12,14,81,83,103,125,131,137,151,168,207,213,229,263,282,288,325,349,374,393,403,416,428,447,470,501,578,603,617],"adolescents,":[13],"survival":[15,258,417],"for":[16,364,377],"metastatic":[17,604],"disease":[18],"remains":[19],"20":[20],"\u2013":[21],"30%.":[22],"1":[23],"Doxorubicin":[24],"(Dox),":[25],"a":[26,351,360,557,581,619],"standard":[27],"agent,":[28],"induces":[29],"immunogenic":[30],"cell":[31],"death,":[32],"but":[33,236,559],"immunosuppressive,":[35],"immunologically":[36,508],"cold":[37,328,509],"tumor":[38,78,220,250],"microenvironment":[39],"(TME)":[40],"limits":[41],"its":[42,378],"efficacy.2":[43],"Combination":[44],"therapy":[45,276],"with":[46,104,173,336,533,589,610],"interleukin-12":[47],"(IL-12)":[48],"can":[49],"potentially":[50],"reshape":[51],"TME,":[53],"yet":[54],"systemic":[55,183],"delivery":[56,450],"of":[57,73,129,342,473,506,574],"IL-12":[58,86,139,224,321,497,531],"constrained":[60],"by":[61,126,154,386,570],"dose-limiting":[62],"toxicity.3":[63],"We":[64,366],"previously":[65],"showed":[66],"that":[67,84,100,306],"A3":[69],"collagen-binding":[70],"domain":[71],"(CBD)":[72],"von":[74],"Willebrand":[75],"factor":[76],"targets":[77],"collagen":[79],"I":[80,206],"III,":[82],"CBD-fused":[85],"(CBD-IL-12)":[87],"localizes":[88],"to":[89,194,268,331,421],"tumors.4":[90],"5":[91],"Because":[92],"OS":[94,115,133,323],"TME":[95,324],"collagen-rich,6":[97],"we":[98],"hypothesized":[99],"CBD-IL-12,":[101],"alone":[102],"Dox,":[105,337],"would":[106],"be":[107],"efficacious":[108],"OS.Methods":[110],"Collagen":[111,204,317,529],"expression":[112],"human":[114,130,212],"was":[116,189,382],"assessed":[117],"using":[118,191],"public":[119],"transcriptomic":[120],"dataset":[121],"(GEO":[122],"GSE99671,":[123],"GSE14359)":[124],"immunofluorescence":[127],"staining":[128],"murine":[132,214,477],"tissue.":[134],"Recombinant":[135],"CBD-IL-12":[136,216,252,319,356,599],"unmodified":[138,223,303],"were":[140,157,209,568],"produced":[141],"HEK293F":[143],"cells.":[144],"Tumor":[145],"accumulation,":[146],"biodistribution,":[147],"anti-tumor":[148,333,537,615],"efficacy,":[149],"survival,":[150,613],"immune":[152,329],"profiling":[153],"flow":[155],"cytometry":[156],"evaluated":[158,190],"two":[160],"syngeneic":[161],"models,":[162],"which":[163],"are":[164],"BVM03O":[165],"(primary,":[166],"p53-mutant)":[167],"K7M2,":[169],"as":[170,177,359],"subcutaneous":[171,261],"tumors,":[172],"K7M2":[174,233,265],"also":[175],"used":[176],"an":[178,440],"experimental":[179],"lung-metastasis":[180],"model.":[181],"Comprehensive":[182],"toxicity":[184,446],"including":[185],"plasma":[186,299],"interferon-gamma":[187],"(IFN-\u03b3)":[188],"healthy":[192,239],"mice":[193],"determine":[195],"addition":[197],"dox":[198],"does":[199],"not":[200,237,248,310],"modulate":[201],"safety":[202,313,353,621],"profile.Results":[203],"type":[205],"III":[208],"abundant":[210],"OS.":[215],"achieved":[217],"4-fold":[218],"higher":[219],"accumulation":[221],"than":[222],"without":[225],"increased":[226,289],"off-target":[227],"uptake,":[228],"selectively":[230],"accumulated":[231],"lung":[234,240,347],"metastases":[235],"(":[241],"figure":[242],"1).":[243],"Although":[244],"Dox":[245,254,308,358],"monotherapy":[246],"did":[247,309],"suppress":[249],"growth,":[251],"plus":[253,357],"significantly":[255],"prolonged":[256],"median":[257],"both":[260],"models":[262],"reduced":[264],"lung-metastatic":[266],"burden":[267],"near-healthy":[269],"levels":[270],"(figure":[271,294,315],"2).":[272,295],"Mechanistically,":[273],"combination":[275],"expanded":[277],"cytotoxic":[278],"KLRG1+CD127\u2212CD8+":[279],"T":[280],"cells":[281,287],"XCR1+":[283],"type-1":[284],"conventional":[285],"dendritic":[286],"M1/M2":[291],"macrophage":[292],"ratio":[293],"CBD":[296],"fusion":[297],"held":[298],"IFN-\u03b3":[300],"~10-fold":[301],"below":[302],"IL-12,":[304],"suggesting":[305],"adding":[307],"compromise":[311],"this":[312],"profile":[314,622],"2).Conclusions":[316],"targeted":[318],"concentrates":[320],"within":[322,601],"modulates":[326],"state":[330],"active":[332],"immunity.":[334],"Combined":[335],"it":[338],"overcomes":[339],"limitations":[341],"single-agent":[343],"therapy,":[344],"controls":[345],"established":[346,507],"metastases,":[348],"preserves":[350,618],"favorable":[352,620],"margin,":[354],"supporting":[355],"clinically":[361],"translatable":[362],"chemo-immunotherapy":[363],"OS.Acknowledgements":[365],"thank":[367],"Research":[368,391,401],"Histology":[369],"Facility":[370],"at":[371],"National":[372],"Heart":[373],"Lung":[375],"Institute":[376],"support.":[379],"This":[380],"research":[381],"funded":[383],"part":[385],"Sarcoma":[387],"UK,":[388],"Bone":[389],"Cancer":[390,400,432],"Trust":[392],"Hannah\u2019s":[394],"Willberry":[395],"Wonder":[396],"Pony":[397],"Charity,":[398],"Pancreatic":[399],"Fund,":[402],"The":[404,554],"Brain":[405],"Tumour":[406],"Charity.References":[407],"Mirabello":[408],"L,":[409,458,489,518],"Troisi":[410],"RJ,":[411],"Savage":[412],"SA.":[413],"incidence":[415],"rates":[418],"from":[419,424],"1973":[420],"2004:":[422],"data":[423],"surveillance,":[426],"epidemiology,":[427],"end":[429],"results":[430],"program.":[431],"2009;115:1531\u20131543.Tacar":[433],"O,":[434],"Sriamornsak":[435],"P,":[436,487,520],"Dass":[437],"CR.":[438],"Doxorubicin:":[439],"update":[441],"on":[442],"anticancer":[443],"molecular":[444],"action,":[445],"novel":[448],"drug":[449],"systems.":[451],"J":[452,479],"Pharm":[453],"Pharmacol.":[454],"2013;65:157\u2013170.Brunda":[455],"MJ,":[456],"Luistro":[457],"Warrier":[459],"RR,":[460],"Wright":[461],"RB,":[462],"Hubbard":[463],"BR,":[464],"Murphy":[465],"M,":[466],"et":[467,494,527],"al.":[468,495,528],"Antitumor":[469],"antimetastatic":[471],"activity":[472],"interleukin":[474],"12":[475],"against":[476,539],"tumors.":[478],"Exp":[480],"Med.":[481],"1993;178:1223\u20131230.Mansurov":[482],"A,":[483,493],"Ishihara":[484,492],"J,":[485],"Hosseinchi":[486],"Potin":[488],"Marchell":[490],"TM,":[491],"Collagen-binding":[496],"enhances":[498,535],"tumour":[499],"inflammation":[500],"drives":[502],"complete":[504],"remission":[505],"mouse":[510],"tumours.":[511],"Nat":[512],"Biomed":[513],"Eng.":[514],"2020;4:531\u2013543.Matsuo":[515],"T,":[516],"Noblecourt":[517],"Kaur":[519],"Wang":[521],"C,":[522],"Chiu":[523],"PC,":[524],"Sasaki":[525],"K,":[526],"targeting":[530],"combined":[532,609],"doxorubicin":[534,611],"effect":[538],"osteosarcoma.":[540],"bioRxiv":[541],"2026;":[542],"doi:":[543],"10.64898/2026.05.07.723520.Corre":[544],"I,":[545],"Verrecchia":[546],"F,":[547,551],"Crenn":[548],"V,":[549],"Redini":[550],"Trichet":[552],"V.":[553],"osteosarcoma":[555],"microenvironment:":[556],"complex":[558],"targetable":[560],"ecosystem.":[561],"Cells":[562],"2020;9:976.Ethics":[563],"Approval":[564],"All":[565],"animal":[566],"experiments":[567],"approved":[569],"ethical":[572],"committees":[573],"Imperial":[575],"College":[576],"London":[577],"performed":[579],"under":[580],"UK":[582],"Home":[583],"Office":[584],"project":[585],"license":[586],"accordance":[588],"Animals":[591],"(Scientific":[592],"Procedures)":[593],"Act":[594],"1986.Abstract":[595],"591":[596,606],"Figure":[597,607],"1Collagen-targeted":[598],"accumulates":[600],"osteosarcomaAbstract":[605],"2CBD-IL-12":[608],"prolongs":[612],"remodels":[614],"immunity":[616]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-06T00:00:00"}